{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:23:22Z","timestamp":1778750602277,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,14]],"date-time":"2014-09-14T00:00:00Z","timestamp":1410652800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1752-1947-8-307","type":"journal-article","created":{"date-parts":[[2014,9,14]],"date-time":"2014-09-14T09:01:01Z","timestamp":1410685261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report"],"prefix":"10.1186","volume":"8","author":[{"given":"Andreas","family":"Kourouklaris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyriakos","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Athanasiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexia","family":"Panagidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiproulla","family":"Demetriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michalis","family":"Zavros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,14]]},"reference":[{"key":"2931_CR1","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1055\/s-0030-1262881","volume":"36","author":"M Bitzan","year":"2010","unstructured":"Bitzan M, Schaefer F, Reymond D: Treatment of typical (enteropathic) hemolytic uremic syndrome. Semin Thromb Hemost. 2010, 36: 594-610. 10.1055\/s-0030-1262881.","journal-title":"Semin Thromb Hemost"},{"key":"2931_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/sj.ki.5001581","volume":"70","author":"N Besbas","year":"2006","unstructured":"Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, Van de Kar N, Zimmerhackl LB: A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int. 2006, 70: 423-431.","journal-title":"Kidney Int"},{"key":"2931_CR3","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","volume":"108","author":"J Caprioli","year":"2006","unstructured":"Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Bettinaglio P, Mele C, Bresin E, Cassis L, Gamba S, Porrati F, Bucchioni S, Monteferrante G, Fang CJ, Liszewski MK, Kavanagh D, Atkinson JP, Remuzzi G: Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood. 2006, 108: 1267-1279. 10.1182\/blood-2005-10-007252.","journal-title":"Blood"},{"key":"2931_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jim.2010.12.020","volume":"365","author":"LT Roumenina","year":"2011","unstructured":"Roumenina LT, Loirat C, Dragon-Durey MA, Halbwachs-Mecarelli L, Sautes-Fridman C, Fremeaux-Bacchi V: Alternative complement pathway assessment in patients with atypical HUS. J Immunol Methods. 2011, 365: 8-26. 10.1016\/j.jim.2010.12.020.","journal-title":"J Immunol Methods"},{"key":"2931_CR5","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, N\u00fcrnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A: Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013, 368: 2169-2181. 10.1056\/NEJMoa1208981.","journal-title":"N Engl J Med"},{"key":"2931_CR6","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/CJN.02210310","volume":"5","author":"M Noris","year":"2010","unstructured":"Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G: Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol. 2010, 5: 1844-1859. 10.2215\/CJN.02210310.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2931_CR7","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1093\/ndt\/gfq160","volume":"25","author":"M Sallee","year":"2010","unstructured":"Sallee M, Daniel L, Piercecchi MD, Jaubert D, Fremeaux-Bacchi V, Berland Y, Burtey S: Myocardial infarction is a complication of factor H-associated atypical HUS. Nephrol Dial Transplant. 2010, 25: 2028-2032. 10.1093\/ndt\/gfq160.","journal-title":"Nephrol Dial Transplant"},{"key":"2931_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","volume":"158","author":"M Scully","year":"2012","unstructured":"Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F, Cheung B, Machin SJ: Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012, 158: 323-335. 10.1111\/j.1365-2141.2012.09167.x.","journal-title":"Br J Haematol"},{"key":"2931_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1750-1172-6-60","volume":"6","author":"C Loirat","year":"2011","unstructured":"Loirat C, Fremeaux-Bacchi V: Atypical hemolytic uremic syndrome. Orphanet J Rare Dis. 2011, 6: 60-10.1186\/1750-1172-6-60.","journal-title":"Orphanet J Rare Dis"},{"key":"2931_CR10","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1056\/NEJMc0808527","volume":"360","author":"J Nurnberger","year":"2009","unstructured":"Nurnberger J, Philipp T, Witzke O, Opazo Saez A, Vester U, Baba HA, Kribben A, Zimmerhackl LB, Janecke AR, Nagel M, Kirschfink M: Eculizumab for atypical hemolytic-uremic syndrome. N Engl J Med. 2009, 360: 542-544. 10.1056\/NEJMc0808527.","journal-title":"N Engl J Med"},{"key":"2931_CR11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1053\/j.ajkd.2011.11.027","volume":"59","author":"G Ariceta","year":"2012","unstructured":"Ariceta G, Arrizabalaga B, Aguirre M, Morteruel E, Lopez-Trascasa M: Eculizumab in the treatment of atypical hemolytic uremic syndrome in infants. Am J Kidney Dis. 2012, 59: 707-710. 10.1053\/j.ajkd.2011.11.027.","journal-title":"Am J Kidney Dis"},{"key":"2931_CR12","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1007\/s00467-012-2283-9","volume":"27","author":"FS Cayci","year":"2012","unstructured":"Cayci FS, Cakar N, Hancer VS, Uncu N, Acar B, Gur G: Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation. Pediatr Nephrol. 2012, 27: 2327-2331. 10.1007\/s00467-012-2283-9.","journal-title":"Pediatr Nephrol"},{"key":"2931_CR13","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/TP.0b013e3181ccd80d","volume":"89","author":"CF Larrea","year":"2010","unstructured":"Larrea CF, Cofan F, Oppenheimer F, Campistol JM, Escolar G, Lozano M: Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation. Transplantation. 2010, 89: 903-904. 10.1097\/TP.0b013e3181ccd80d.","journal-title":"Transplantation"},{"key":"2931_CR14","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.2215\/CJN.01090209","volume":"4","author":"CJ Mache","year":"2009","unstructured":"Mache CJ, Acham-Roschitz B, Fremeaux-Bacchi V, Kirschfink M, Zipfel PF, Roedl S, Vester U, Ring E: Complement inhibitor eculizumab in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol. 2009, 4: 1312-1316. 10.2215\/CJN.01090209.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2931_CR15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrneph.2012.214","volume":"8","author":"J Zuber","year":"2012","unstructured":"Zuber J, Fakhouri F, Roumenina LT, Loirat C, Fremeaux-Bacchi V: Use of eculizumab for atypical haemolyticuraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol. 2012, 8: 643-657. 10.1038\/nrneph.2012.214.","journal-title":"Nat Rev Nephrol"},{"key":"2931_CR16","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s00467-012-2276-8","volume":"27","author":"R Vilalta","year":"2012","unstructured":"Vilalta R, Lara E, Madrid A, Chocron S, Mu\u00f1oz M, Casquero A, Nieto J: Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome. Pediatr Nephrol. 2012, 27: 2323-2326. 10.1007\/s00467-012-2276-8.","journal-title":"Pediatr Nephrol"},{"key":"2931_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1046\/j.1538-7836.2003.00169.x","volume":"1","author":"HM Tsai","year":"2003","unstructured":"Tsai HM: Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes. J Thromb Haemost Apr. 2003, 1: 625-631. 10.1046\/j.1538-7836.2003.00169.x.","journal-title":"J Thromb Haemost Apr"},{"key":"2931_CR18","doi-asserted-by":"publisher","first-page":"e10208","DOI":"10.1371\/journal.pone.0010208","volume":"5","author":"P Coppo","year":"2010","unstructured":"Coppo P, Schwarzinger M, Buffet M, Wynckel A, Clabault K, Presne C, Poullin P, Malot S, Vanhille P, Azoulay E, Galicier L, Lemiale V, Mira JP, Ridel C, Rondeau E, Pourrat J, Girault S, Bordessoule D, Saheb S, Ramakers M, Hamidou M, Vernant JP, Guidet B, Wolf M, Veyradier A: Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience. PLoS One. 2010, 5: e10208-10.1371\/journal.pone.0010208.","journal-title":"PLoS One"},{"key":"2931_CR19","first-page":"859","volume":"21","author":"F Fakhouri","year":"2010","unstructured":"Fakhouri F, Roumenina L, Provot F, Sall\u00e9e M, Caillard S, Couzi L, Essig M, Ribes D, Dragon-Durey MA, Bridoux F, Rondeau E, Fr\u00e9meaux-Bacchi V: Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am SocNephrol. 2010, 21: 859-867.","journal-title":"J Am SocNephrol"},{"key":"2931_CR20","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2215\/CJN.04760512","volume":"8","author":"V Fremeaux-Bacchi","year":"2013","unstructured":"Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaim\u00e9 F, Dragon-Durey MA, Ngo S, Moulin B, Servais A, Provot F, Rostaing L, Burtey S, Niaudet P, Desch\u00eanes G, Lebranchu Y, Zuber J, Loirat C: Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol. 2013, 8: 554-562. 10.2215\/CJN.04760512.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2931_CR21","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1111\/j.1600-6143.2012.04252.x","volume":"12","author":"J Zuber","year":"2012","unstructured":"Zuber J, Le Quintrec M, Krid S, Bertoye C, Gueutin V, Lahoche A, Heyne N, Ardissino G, Chatelet V, No\u00ebl LH, Hourmant M, Niaudet P, Fr\u00e9meaux-Bacchi V, Rondeau E, Legendre C, Loirat C: Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. Am J Transplant. 2012, 12: 3337-3354. 10.1111\/j.1600-6143.2012.04252.x.","journal-title":"Am J Transplant"},{"key":"2931_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.molimm.2012.10.044","volume":"54","author":"S Heinen","year":"2013","unstructured":"Heinen S, Pluthero FG, van Eimeren VF, Quaggin SE, Licht C: Monitoring and modeling treatment of atypical hemolytic uremic syndrome. Mol Immunol. 2013, 54: 84-88. 10.1016\/j.molimm.2012.10.044.","journal-title":"Mol Immunol"},{"key":"2931_CR23","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1016\/j.transproceed.2010.09.125","volume":"42","author":"V Chatelet","year":"2010","unstructured":"Chatelet V, Lobbedez T, Fremeaux-Bacchi V, Ficheux M, Ryckelynck JP, Hurault de Ligny B: Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report. Transplant Proc. 2010, 42: 4353-4355. 10.1016\/j.transproceed.2010.09.125.","journal-title":"Transplant Proc"},{"key":"2931_CR24","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1172\/JCI118195","volume":"96","author":"CS Rinder","year":"1995","unstructured":"Rinder CS, Rinder HM, Smith BR, Fitch JC, Smith MJ, Tracey JB, Matis LA, Squinto SP, Rollins SA: Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest. 1995, 96: 1564-1572. 10.1172\/JCI118195.","journal-title":"J Clin Invest"},{"key":"2931_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrneph.2010.155","volume":"7","author":"J Zuber","year":"2011","unstructured":"Zuber J, Le Quintrec M, Sberro-Soussan R, Loirat C, Fremeaux-Bacchi V, Legendre C: New insights into postrenal transplant hemolytic uremic syndrome. Nat Rev Nephrol. 2011, 7: 23-35. 10.1038\/nrneph.2010.155.","journal-title":"Nat Rev Nephrol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-8-307\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T05:50:38Z","timestamp":1630561838000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-8-307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,14]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2931"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-8-307","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,14]]},"assertion":[{"value":"16 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"307"}}